SNS-101

· Sensei Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNS-101, covering 2025-08-15 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing